Carcinostatic activity of yemenimycin.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010455:Peptides; C003778:yemenimycin